SlideServe
Menu
Préférences
© SlideServe · v2026

Understanding CHR Approval Processes for Human Research Studies

isaiah-lester avatar
16 diapositives · 314 Views · Nov 16, 2014

This guide provides essential information on the Committee on Human Research (CHR) processes necessary for conducting studies involving human subjects at UCSF. It clarifies whether your study qualifies as research, whether it involves human subjects, and the type of CHR review required (full, expedited, or exempt). The document outlines resources available for training and education, such as the UCSF Human Research Protection Training, as well as decision algorithms for determining CHR review needs. Comprehensive guidance is provided to ensure ethical conduct in research.

Understanding CHR Approval Processes for Human Research Studies - slide 1
01 / 16Understanding CHR Approval Processes for Human Research Studies
1 / 17

Télécharger la présentation

Understanding CHR Approval Processes for Human Research Studies
Une image / un lien ci-dessous est fourni (tel quel) pour télécharger la présentation

Politique de téléchargement : le contenu du site vous est fourni TEL QUEL pour votre information et votre usage personnel ; il ne peut être vendu, concédé sous licence ni partagé sur d’autres sites sans l’accord de son auteur.Le contenu vous est fourni TEL QUEL, pour votre information et votre usage personnel uniquement. Téléchargez la présentation en cliquant sur ce lien. Lors du téléchargement, si vous ne parvenez pas à télécharger une présentation, l’éditeur a peut-être supprimé le fichier de son serveur.Pendant le téléchargement, si vous ne parvenez pas à obtenir une présentation, le fichier a peut-être été supprimé par l’éditeur.

F I N

Plus de contenu associé

Transcription de la présentation
  1. Committee on Human Research Processes Clinical Translational Research Fellowship Program Curriculum Core

  2. Objective Clarify Committee on Human Research (CHR) processes for your study. Is it research? Is it human subjects? Type of review? Resources

  3. CHR Processes • UCSF Human Research Protection Training and Education Resources • http://www.research.ucsf.edu/chr/Train/chrTrain.asp#Basic

  4. Prior to moving forward with your study • Determine • whether your study is a research study • whether your study involves a human subject • Type of CHR review

  5. What is research? • Research is the “systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge.” • http://www.research.ucsf.edu/chr/about/chrfaq.asp

  6. Is my quality improvement project research? • If you are collecting data to disseminate/apply to other populations, then generally CHR approval is required. • If you are conducting a quality improvement project, CHR approval is not required. • See website/decision algorithm for greater detail: • http://www.research.ucsf.edu/chr/Apply/RefGuide.asp • http://www.research.ucsf.edu/chr/Guide/HSDecisTree.pdf

  7. Definition of Human Subjects • A living individual about whom an investigator (whether professional or student) conducting research obtains (1) data through intervention or interaction with the individual, or (2) identifiable private information [45 CFR 46.102(f)] • If your study is a research study involving a human subject, your study requires a CHR approval.

  8. Do students need to submit their proposal for CHR review and approval? • The Committee on Human Research (CHR) must review all research that involve human subjects performed by UCSF faculty, staff, or students. • http://www.research.ucsf.edu/chr/about/chrfaq.asp

  9. Types of CHR Review • Full committee, expedited, and exempt are three types of CHR review; the type of review is based on the level of risk in your study • Minimal risk is the probability and magnitude of harm or discomfort anticipated in the research. Minimal risks are not greater than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests.

  10. Types of CHR Review • Studies with greater than minimal risk → Full CHR review Examples: randomized studies, studies using an investigational drug • Studies with no greater than minimal risk → Expedited or exempt CHR review • For more details, see • http://www.research.ucsf.edu/chr/Guide/AppCommRevGI.asp#Type

  11. Do you need to do the on-line Collaborative Institutional Training Initiative (CITI) Training? Yes, if you are “key personnel.” Key personnel are defined as: “…all individuals who contribute in a substantive way to the scientific development or execution of the study at or on behalf of UCSF or affiliated institutions. Typically, these individuals have doctoral or other professional degrees, although other individuals should be included if their involvement meets the definition of Key Personnel. In particular, investigators and staff involved in obtaining informed consent are considered Key Personnel.” http://www.research.ucsf.edu/chr/Train/CITI_FAQ.asp#key

  12. Prior to moving forward with your study • If your research proposal is linked to an existing research study, ask your mentor to see their CHR documents. • Carefully review the sections on risks, benefits and vulnerable groups • Review the consent forms. • Will your study pose any new risks? Will new tools be administered to subjects?

  13. Prior to moving forward with your study Can a minor modification to an existing protocol be submitted? or, Do you need to submit a new application?

  14. Where to go for help • UCSF Human Research Protection Program • http://www.research.ucsf.edu/chr/ • Your mentor • CTSI Ethics Consultation • http://ctsi.ucsf.edu/consult

  15. Summary • Research involving a human subject requires CHR approval • Many resources are available at UCSF for the ethical conduct of research

  16. CTRFP* Curriculum Core • Rebecca Jackson MD, School of Medicine • Barbara J. Burgel, RN, PhD, School of Nursing • George Sawaya MD, School of Medicine • Susan Hyde DDS, MPH, PhD, School of Dentistry • Jaekyu Shin, PharmD, School of Pharmacy • Joel Palefsky MD, School of Medicine * Clinical Translational Research Fellowship Program